Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany.
Rohrbacher
M
M
Berger
U
U
Hochhaus
A
A
Metzgeroth
G
G
Adam
K
K
Lahaye
T
T
Saussele
S
S
Müller
M C
MC
Hasford
J
J
Heimpel
H
H
Hehlmann
R
R
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D002173:Cancer Care Facilities / Q000706:statistics & numerical data; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D005260:Female; D005858:Germany / Q000453:epidemiology; D006764:Hospitals, Community / Q000706:statistics & numerical data; D006776:Hospitals, Pediatric / Q000706:statistics & numerical data; D006785:Hospitals, University / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000453:epidemiology*; D011331:Private Practice / Q000706:statistics & numerical data; D055815:Young Adult